NCT06365840 2026-04-17
TMB-H
ImmuneOncia Therapeutics Inc.
Phase 2 Recruiting
Clinical Trials
6 trialsNCT05393713 2025-12-03
Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study
Mayo Clinic
Phase 1 Terminated
NCT04414163 2025-06-18
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
ImmuneOncia Therapeutics Inc.
Phase 2 Active not recruiting
NCT04196465 2025-04-10
NeoChance
Asan Medical Center
Phase 2 Active not recruiting
NCT03999658 2023-05-01
A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies
Sorrento Therapeutics, Inc.
Phase 2 Withdrawn
NCT03644056 2020-05-28
Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors
ImmuneOncia Therapeutics Inc.
Phase 1 Completed